Chari, A., Donk, N. W. C. J. V. D., Dholaria, B., Weisel, K., Mateos, M., Goldschmidt, H., Martin, T. G., Morillo, D., Reece, D., Rodriguez-Otero, P., Bhutani, M., D’Souza, A., Oriol, A., Rosiñol, L., Bahlis, N. J., Vishwamitra, D., Skerget, S., Verona, R. I., Bakshi, K., Kang, L., Prior, T. J., Vandenberk, L., Tolbert, J., Lee, S., Smit, M. D., Wäsch, R. (2025). Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study. Blood. https://doi.org/10.1182/blood.2025029360